AbbVie Inc.
ABBV · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $188,000 | $941,000 | $1,289,000 | $4,286,000 |
| Dep. & Amort. | $2,063,000 | $2,050,000 | $2,039,000 | $2,102,000 |
| Deferred Tax | $193,000 | -$272,000 | -$28,000 | -$767,000 |
| Stock-Based Comp. | $209,000 | $179,000 | $410,000 | $674,000 |
| Change in WC | $3,142,000 | -$562,000 | -$2,580,000 | -$397,000 |
| Other Non-Cash | $1,229,000 | $2,817,000 | $505,000 | $1,150,000 |
| Operating Cash Flow | $7,024,000 | $5,153,000 | $1,635,000 | $7,048,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $504,000 | -$269,000 | -$235,000 | -$291,000 |
| Net Acquisitions | $1,274,000 | -$940,000 | -$538,000 | -$1,792,000 |
| Inv. Purchases | -$7,000 | -$12,000 | -$10,000 | -$27,000 |
| Inv. Sales/Matur. | $3,000 | $7,000 | $32,000 | $39,000 |
| Other Inv. Act. | -$5,038,000 | $33,000 | $16,000 | $197,000 |
| Investing Cash Flow | -$3,264,000 | -$1,181,000 | -$735,000 | -$1,874,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,775,000 | $209,000 | $2,561,000 | -$3,762,000 |
| Stock Issued | -$977,000 | $0 | $0 | $0 |
| Stock Repurch. | $4,000 | -$12,000 | -$961,000 | -$358,000 |
| Dividends Paid | -$2,911,000 | -$2,910,000 | -$2,925,000 | -$2,752,000 |
| Other Fin. Act. | $1,069,000 | $3,000 | $67,000 | $11,000 |
| Financing Cash Flow | -$4,590,000 | -$2,710,000 | -$1,258,000 | -$6,861,000 |
| Forex Effect | -$8,000 | $30,000 | $9,000 | -$46,000 |
| Net Chg. in Cash | -$838,000 | $1,292,000 | -$349,000 | -$1,733,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,467,000 | $5,175,000 | $5,524,000 | $7,257,000 |
| End Cash | $5,629,000 | $6,467,000 | $5,175,000 | $5,524,000 |
| Free Cash Flow | $7,528,000 | $4,884,000 | $1,400,000 | $6,757,000 |